Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03769116 |
|---|---|
| Brief Title: | A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD) |
| First Submitted : | December 6, 2018 |
| First Submitted that Met QC Criteria : | December 6, 2018 |
| First Posted : | December 7, 2018 |
| Results First Submitted : | July 5, 2023 |
| Results First Posted with QC Comments : | July 27, 2023 |
| Results First Submitted that Met QC Criteria : | September 13, 2023 |
| Results First Posted : | September 15, 2023 |
| Certification/Extension First Submitted : | December 1, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | September 13, 2023 |
| Certification/Extension First Posted : | September 15, 2023 |
| Last Update Submitted that Met QC Criteria : | October 10, 2023 |
| Last Update Posted : | October 25, 2023 |